These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34838278)

  • 1. Comparison of the Psychometric Properties of the EQ-5D-3L-Y and EQ-5D-5L-Y Instruments in Spanish Children and Adolescents.
    Pérez-Sousa MÁ; Olivares PR; Ramírez-Vélez R; Gusi N
    Value Health; 2021 Dec; 24(12):1799-1806. PubMed ID: 34838278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric Properties of the Spanish Versions of EQ-5D-Y-3L and EQ-5D-Y-5L in Children with Cancer: A Comparative Study.
    Perez-Sousa MA; Olivares PR; Gusi N
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi.
    Ngwira LG; Maheswaran H; Verstraete J; Petrou S; Niessen L; Smith SC
    J Patient Rep Outcomes; 2023 Mar; 7(1):22. PubMed ID: 36892714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis.
    Lin J; Wong CKH; Cheung JPY; Cheung PWH; Luo N
    Eur J Health Econ; 2022 Nov; 23(8):1383-1395. PubMed ID: 35122171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Measurement Properties of the English EQ-5D-Y 3-Level Version With the 5-Level Version in South Africa.
    Verstraete J; Amien R; Scott D
    Value Health Reg Issues; 2022 Jul; 30():140-147. PubMed ID: 35429927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of the Psychometric Properties of the EQ-5D-Y-3L and EQ-5D-Y-5L Using Paediatric Multi-Instrument Comparison (P-MIC) Study Data.
    Bahrampour M; Devlin N; Jones R; Dalziel K; Mulhern B;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):95-111. PubMed ID: 38748193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds.
    van Heusden A; Rivero-Arias O; Herdman M; Hiscock H; Devlin N; Dalziel K;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):129-145. PubMed ID: 38238604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care.
    Verstraete J; Marthinus Z; Dix-Peek S; Scott D
    Health Qual Life Outcomes; 2022 Feb; 20(1):28. PubMed ID: 35177084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the psychometric properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, CHU-9D, and PedsQL in children and adolescents with osteogenesis imperfecta.
    Xu RH; Zhu L; Sun R; Tan RL; Luo N; Zou S; Dong D
    Eur J Pediatr; 2022 Dec; 181(12):4049-4058. PubMed ID: 36156120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.
    Yfantopoulos J; Chantzaras A; Kontodimas S
    Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea.
    Kim SH; Kim HJ; Lee SI; Jo MW
    Qual Life Res; 2012 Aug; 21(6):1065-73. PubMed ID: 21947656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia.
    Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F
    Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
    Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
    Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population.
    Kangwanrattanakul K; Parmontree P
    Qual Life Res; 2020 Dec; 29(12):3407-3417. PubMed ID: 32780315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The performance of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents with cerebral palsy (CP).
    Verstraete J; Scott D
    Dialogues Health; 2022 Dec; 1():100032. PubMed ID: 38515901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression.
    O'Loughlin R; Jones R; Chen G; Mulhern B; Hiscock H; Devlin N; Dalziel K;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):57-77. PubMed ID: 38329689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison Study.
    Jones R; O'Loughlin R; Xiong X; Bahrampour M; Devlin N; Hiscock H; Chen G; Mulhern B; Dalziel K;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):39-55. PubMed ID: 37955799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
    Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
    Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the EQ-5D-Y-5L parent-proxy version among children with juvenile idiopathic arthritis.
    Ohinmaa A; Wen J; Currie GR; Benseler SM; Swart JF; Vastert SJ; Yeung RSM; Marshall DA
    Qual Life Res; 2024 Oct; 33(10):2677-2691. PubMed ID: 39141175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.